...as Sygen-ORx Bioscience, set to revolutionize healthcare industry
LAGOS, NIGERIA - On August 16th, 2024, at the prestigious Marriot Hotel in Ikeja, Lagos, a historic event took place, marking a significant milestone in the healthcare industry.
Sygen Pharmaceuticals Ltd and ORx Pharmaceuticals of Ontario, Canada, announced the formation of a joint venture, Sygen-ORx Bioscience, aimed at transforming healthcare through collaborative innovation.
The event was graced by the presence of HRM Prof. Alexander Macgregor, Chairman of ORx Pharmaceuticals, who attended alongside his wife.
Prof. Macgregor, a renowned figure in the pharmaceutical industry, expressed his enthusiasm for the joint venture, stating, "This partnership represents a major leap forward in our quest to improve patient care and advance medical science.
"By combining our expertise and resources, we are poised to make a significant impact in the healthcare landscape."
Additionally, the Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Moji Adeyeye, was also present at the occasion, lending her support to the groundbreaking partnership.
Her presence underscored the significance of the joint venture in advancing the country's healthcare sector.
The joint venture brings together two industry leaders, leveraging ORx Pharmaceuticals' extensive experience in developing and commercializing transformative therapies across various therapeutic areas.
ORx has earned a reputation as a leader in the pharmaceutical industry, guided by a vision of excellence and led by a dedicated team of professionals.
Sygen Pharmaceuticals, known for its pioneering spirit and commitment to scientific rigor, complements ORx's strengths with its innovative approach to healthcare solutions.
With a focus on developing high-quality medications and enhancing access to innovative treatments, Sygen has established itself as a trusted partner in driving positive change in Nigeria's healthcare landscape.
The formation of Sygen-ORx Bioscience marks a significant milestone in the healthcare industry, promising to deliver groundbreaking solutions through collaborative innovation.
By combining their expertise and resources, Sygen and ORx aim to improve patient care and advance medical science, solidifying their position as leaders in the pharmaceutical industry.
Further details about the joint venture and its future plans will be announced in the coming months.
No comments:
Post a Comment